The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
Ukraine to receive EUR 85 mln grant through EBRD for gas purchase – Shmyhal
10:31, 27.01.2026
Amber Dragon Ukraine Infrastructure Fund I announces its first closing of EUR 200 mln
18:41, 21.01.2026
EBRD has invested EUR 9.2 bln in 25 projects in Ukraine since start of full-scale war – Vice President
16:25, 20.01.2026
EBRD provides OTP Leasing with local-currency equivalent of EUR 20 mln loan to support MSMEs
17:44, 07.01.2026
EBRD provides Credit Agricole Bank EUR 150 mln guarantee for business lending
09:57, 03.12.2025
LATEST
Kernel plans to invest in green energy, interested in bioethanol production, logistics
20:56, 30.01.2026
Kyivstar conducts a $131.3 mln SPO with upside to $150.9 mln, shares fall 6.6%
20:53, 30.01.2026
Kernel switches production of Shchedry Dar, Stozhar bottled oil to green energy from sunflower husks
18:01, 30.01.2026
Cabinet expands coverage under business war risk insurance program, simplifies application submission – Svyrydenko
14:10, 30.01.2026
EU allocates EUR 10 mln for development of digital services in Ukraine – ministry